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Abstract: 
Background and Objective 
The problem of antimicrobial resistance (AMR) has assumed pandemic dimensions 
especially among low and middle income countries such as Nigeria. Irrational use of 
currently available antimicrobial agents is a major contributory factor. There remains a 
paucity of documented information on the determinants of antibiotics prescribing 
among physicians in Nigeria to guide future strategies to reduce AMR. This study 
therefore aimed to investigate the patterns and determinants of antibiotics prescription 
among doctors in a tertiary hospital in Nigeria as the first step to improve future 
antibiotic use in hospitals. 
Methodology 
A cross sectional survey of the determinants of antibiotic prescribing among doctors in 
the Lagos State University Teaching Hospital, Ikeja, was performed using a structured 
questionnaire. Information was obtained about the doctors and the factors determining 
their prescription of antibiotics. The results were summarized using descriptive statistics 
with Statistical Package for Social Science (SPSS). 
Results 
98 respondents were studied with a mean age of 36.24(9.01) years, mean duration of 
practice of 10.68(9.25) years, and mainly males (64.3%). 97% prescribe antibiotics 
frequently, mostly based on clinical judgment and experience with rare laboratory 
supports. Factors of cost, drug availability and information from pharmaceutical 
representatives influenced antibiotic prescribing. There were indications of non-
existence or non-functional institutional policies and guidelines regarding antimicrobial 
therapies.  
Conclusion 
There is an urgent need to institute evidence based institutional policies and guidelines 
for improving antimicrobial use among hospitals in Nigeria. This is already being 
followed up 
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1. Introduction 
The problem of antimicrobial resistance (AMR) has assumed pandemic dimensions 
especially among Low and Middle Income Countries (LMICs) such as Nigeria [1,2]. 
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AMR now poses a serious threat to global health, increasing morbidity, mortality and 
costs if not addressed [3-7]. Recent reports revealed its occurrence in all regions of the 
world and the potential to affect anyone, of any age, and in any country, leading to calls 
to develop appropriate plans across countries [8,9]. Records of resistance to carbapenem 
antibiotics that are used as last resort for life threatening infections now exist in practically 
all regions of the world. [1] Similarly, there is increasing resistance to widely used third 
generation cephalosporins and fluoroquinolones occasioned by increasing use of 
antibiotics [1,10]. This has led to calls for international collaboration to reduce future 
rates of AMR including calls by World Health Assembly to member states to publish 
their national action plans towards combating drug resistant infections especially 
antibiotic resistant bacteria with a deadline which expired in May 2017 without 
satisfactory responses.  [8, 11, 12, 13]. 
The prevalence of AMR documented across Africa, including Nigeria, remains 
high [2, 14-15]. . As a resultin Nigeria, there is a substantial decline in the susceptibility 
of antibiotics commonly used for  empirical treatments.. Examples include 88% of 
Staphylococcus aureus infections now resistant to methicillin, over 98% resistance to β-
lactam antibiotics in post-operative wound infections, susceptibility rates below 60% to 
empiric antibiotics in urinary tract isolates and below 50% for antibiotics used for 
empiric treatment of patients with community acquired pneumonia [16-18]. 
Major contributory factors to AMR are the irrational use of currently available 
antibiotics and uncurtailed access to antibiotics [19]. These factors have resulted in 
excessive use of antibiotics with resultant increase in AMR and concomitant strains on 
the health care systems [2, 6, 20-22]. Other predisposing factors to AMR include  
healthcare environment factors such as regulatory policies and infection control practices, 
lack of guidelines as well as patient pressure [23-25]. 
Globally, there is evidence that prescribing physicians still have limited 
knowledge and incorrect practices regarding antibiotic prescribing [26]. Factors 
influencing physicians prescribing of antibiotics include the severity and duration of 
infections, patient’s expectations, fear of complications, diagnostic uncertainties and the 
influence of pharmaceutical companies [26-28]. Inappropriate antibiotic prescribing can 
also emanate from contextual factors such as a lack of existing guidelines, cultural factors 
such as the influence of peers, and behavioural factors such as the perception of decision 
autonomy by prescribers. [29]. Prescribing etiquette is also seen as as a major determinant 
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of antibiotic prescribing practices among physicians. [30]. Furthermore, Calbo et al in 
their review also outlined physicians’ level of training, motivation, work load, practice 
settings, access to diagnostic techniques, and services of infectious diseases consultants, 
as factors influencing antibiotic prescribing [31]. 
The benefits of appropriate antibiotic prescribing include direct positive impact on 
clinical outcomes, efficient use of healthcare resources, avoidance or reduction of 
adverse drug effects as well as the prevention of emergence of drug resistant bacteria 
[6,23,31]. To undertake this and reduce AMR, physicians need adequate knowledge of 
the patterns of antimicrobial sensitivity in their facilities as well as comply with 
approved evidence based guidelines [32,33]. This can be part of antimicrobial 
stewardship programmes (ASPs), which have proven to be effective with improving 
subsequent antibiotic use [34, 35]. ASPs should be designed with knowledge of the 
determinants of antimicrobial prescribing among physicians, with acknowledgement 
that much work still needs to be undertaken around such initiatives in LMICs [29, 36].  
There remains paucity of documented information on the determinants of antibiotics 
prescribing among physicians in Nigeria, which is important given that Nigeria is the 
most populous African nation coupled with the high burden of infectious diseases in 
sub-Sahara Africa [32, 37, 38]. This study therefore aimed to investigate the patterns 
and determinants of antibiotic prescribing among doctors in a tertiary hospital in 
Nigeria as the first step to improve future antibiotic use in hospitals. This survey also 
serves as a pilot for a national survey on the subject across Nigeria  
 
2. Methodology 
The study design was a quantitative cross sectional survey conducted among the 
prescribing doctors who attended a hospital grand round on the subject of the rational 
use of antibiotics at the Lagos State University Teaching Hospital, in Ikeja, Lagos, 
Nigeria. This included whether prescriptions are for originators or generics (INN – 
International non-proprietary name) since the cost of medicines is mostly out-of-pocket. 
The hospital is a major referral center in Lagos metropolis with a bed capacity of 774 
beds and is one of three tertiary centers serving an estimated catchments population of 
over 19 million people in Lagos State, Nigeria. Consequently, if there are concerns with 
antibiotic prescribing in this centre, such concerns may well be magnified in non-
teaching hospitals including secondary hospitals. A self-administered structured 
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questionnaire was used to collect data comprising of the socio demographic 
characteristics of the doctors and the potential factors determining their prescription of 
antibiotics prior to the delivery of a presentation by one of the co-authors (OO). There 
were169 prescribing doctors employed by the hospital at the time of the survey. All 98 
doctors who were in attendance at the grand round when the presentation was delivered 
participated. Respondents maintained anonymity as they did not require documenting 
any identifiable personal information.  
 
2.1.Ethical Approval 
The study received ethical approval from the Hospital Ethics Committee and verbal 
consent was received from the responding participants. 
2.2. Statistical Analysis 
 Statistical tests were performed using Statistical Package for Social Science version 
15.0. Data explored and the results were summarized with descriptive statistics. 
Continuous variables were expressed as mean with standard deviation and categorical 
variables as proportions. 
 
3. Results 
Among the 98 (58%) respondents, 63 were males (64.3%) and 35 females (35.7%), with 
a good representation of most clinical specialties and professional ranking/status of 
doctors in the hospital at that time (Figures 1 and 2).  
Figure 1 – Clinical speciality of respondents 
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Figure 2 – Professional status 
 
 
Their mean age was 36.24(9.01) years and mean duration of professional practice 
was10.68 (9.25) years.  The majority of the doctors (97%) prescribed antibiotics in their 
daily practices. Over 97% indicated that their choices were influenced by drug 
promotional and marketing activities of pharmaceutical industry. Other major factors 
influencing prescribing included the use of clinical judgment (93.9%), professional 
experience (87.8%), as well as consideration of the costs to patients (80.6%), as most 
patients pay out of pocket, and drug availability (80.6%). Positively, over 70% of 
respondents indicated that they consider local epidemiology of bacterial infections, 
literature evidence and a senior colleagues’ decision in their prescribing decision. 
However, only 45.9% indicated that their choice of antibiotic considered laboratory 
results. Inclination to follow the unit policy/protocol was seen among only 43.9% of 
responders, and the use of hospital policy/treatment guidelines was only 8.2% (Table: 
1). 
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Table 1: Factors Determining Antibiotics Prescription among Respondents 
Factor Frequency (N) Percentage (%) 
Drug Promotional and 
Marketing Influences                                    
96 97.9 
Clinical Judgment (without 
laboratory result) 
91 93.9 
Experience 86 87.8 
Cost to Patients 79 80.6 
Drug Availability 79 80.6 
Epidemiology of Infection 74 75.5 
Best Evidence (Literature) 70 71.4 
Senior Colleague’s Decision 69 70.4 
Laboratory Results 45 45.9 
Unit Policy 43 43.9 
Hospital Policy (Treatment 
Guideline) 
8 8.2 
 
In terms of the doctor’s choices in prescribing, the duration of antibiotic 
treatment, and the factors determining those choices, 39.8% of doctors indicated their 
prescription is individualized considering patient specific conditions.  35.7% preferred 
to prescribe for 1 week, 15.3% indicated they preferred 5 days of treatment and 9.2% 
preferred to treat for more than a week. The natures of illness (56.1%), and the severity 
of infections (39.8%), were the major determinants for choosing the duration of 
antibiotic treatment. Consideration for the clinical response to treatment was 22.4%, and 
to the pharmacokinetic and pharmacodynamic properties of the antibiotic was 7.1% 
(Table 2a, 2b). 
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Table 2 a: Duration of Antibiotics Prescription 
Duration Frequency % 
Patient Specific 39 39.8 
1 week 35 35.7 
5 days 15 15.3 
>1 week 9 9.2 
Total 98 100 
 
Table 2b: Factors Determining Choice of Duration of Antibiotics Prescriptions 
Factor Frequency % 
Nature of infection 55 56.1 
Severity of infection 39 39.8 
Clinical Response of Patient 22 22.4 
Properties of Drug 7 7.1 
 
Nearly three quarters (72.4%) of respondents indicated that they prescribe both 
generic and branded products interchangeably whilst only 5.1% exclusively prescribed 
branded products and 22.45% generic products using the International Non-proprietary 
Names (INN) (Table: 3). 74% and 82% of respondents were unaware of the unit and 
hospital guidelines for antimicrobial therapies respectively.  
Table 3: Form of Prescriptions 
Form Frequency % 
Generic and Branded 
(Interchangeably) 
71 72.4 
Generic (Exclusively) 22 22.4 
Branded (Exclusively) 5 5.1 
 
4. Discussion 
The finding that 97% respondents from most clinical specialties prescribed antibiotics in 
their daily practice is indicative of the universality of antibiotic use in clinical practice 
in Nigeria, suggesting the importance of the topic and their rational use. Concerns seen 
in this initial study include the fact that over 97% of the doctors alluded to drug 
promotional and marketing activities influencing their prescribing in some way. This 
reveals the extent to which drug promotion is prevalent in Nigeria. Even though 
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findings from previous studies indicated that the interactions between doctors and the 
pharmaceutical industries could be mutually beneficial, it is also potentially 
controversial especially if only biased information is supplied alongside financial 
rewards [ 39,40]. While some studies argue that physicians believed their prescribing 
behavior are not easily influenced by the interactions with pharmaceutical 
representatives as they are able to objectively evaluate such information [41,42], other 
study demonstrated a significant increase in drug use in subsequent months after 
promotional activities by pharmaceutical companies [43].Consequently, this is an 
important factor to consider in planning interventional measures towards promoting 
rationale antibiotic prescribing. Physician education around rational medicine use has 
worked well in other countries to reduce the influence of pharmaceutical companies and 
enhance rational prescribing behavior [44,45]. Inappropriate antibiotic prescribing is 
known to emanate from the trio of behavioural, cultural and contextual factors [28].  
           Another concern is the high rate of prescribing relying on clinical judgment 
(94%) and professional experience (88%) rather than approved local guidelines based 
on antibiograms. These findings are indicative of highly prevalent ‘decision autonomy’ 
in antibiotic prescribing in hospitals in Nigeria, which urgently needs to be addressed.  
This could be due to the lack of functioning hospital Drugs and Therapeutic Committee 
(DTC), approved hospital and unit policies governing antibiotic prescribing practices, 
instigation of ASPs, inadequate and timely laboratory support and the lack of a reliable 
supply of antibiotics for uninterrupted duration of treatment. [46-48]. 
           Encouragingly, 76% of the respondents took the epidemiology of infection into 
consideration when prescribing antibiotics while 71% alluded to best evidence 
influencing their prescribing practices. However, the influence of pharmaceutical 
companies as well as senior colleague’s in determining antibiotics prescription is a 
concern especially if this leads to inappropriate antibiotic prescribing [30]. The high 
proportion of antibiotic prescribing influenced by senior colleague’s decisions can be 
explained by the fact that the majority of respondents (over 64%) in this study were 
trainees. The finding that 44% of respondents were aware of the existence of some form 
of unit based policy on antibiotics could be a reflection of senior colleague’s driven 
practices in their respective clinical units. However, the low percentage of respondents 
(8%) who were aware of any hospital based antibiotic policy strongly suggests the lack 
of existence or implementation of such policies, which urgently needs to be addressed 
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along with the establishment of ASPs to improve future antibiotic prescribing. As 
mentioned, ASPs have been found to be effective to help improve antibiotic prescribing 
and reduce AMR [35, 49]. ASPs have helped promote the rational uses of 
antimicrobials through formulary restrictions, pre-authorization, monitoring, audit and 
feedback exercises as well as guideline development [50]. Functional ASPs in the 
hospital should address discrepancies and concerns highlighted in Table 2a and Table 
2b by standardizing appropriate antibiotics use. This builds on national initiatives on-
going in other African countries such as Ghana and South Africa to improve antibiotic 
prescribing [51, 52].  
         Most respondents (over 72%) in this survey prescribed antibiotics in both generic 
and branded forms interchangeably while 22% prescribed in generic form exclusively 
(Table 3). While the survey did not explore the rationale behind these practices in detail, 
they may be informed by the concerns with the safety and efficacy of generics in 
Nigeria, as well as issues of affordability as many patients pay from their pockets and  
the influence of promotional activities [53, 54]. These issues and associated concerns 
will be explored in future studies. 
 
Study Limitations 
We are aware that only 58% of the total number of doctors in the hospital took part. In 
addition, the proportion of the respondents who were senior doctors was relatively low 
compared to the total respondents. However, the representation of most clinical 
specialties and all professional cadres of doctors in this survey suggests that the findings 
could be indicative of the determinants for antibiotic prescribing practices across the 
clinical disciplines in this hospital adding robustness to the findings. While the findings 
in this survey may not necessarily be generalizable to the entire Nigerian clinical 
population, we believe they constitute useful indications of the likely problems 
regarding antibiotic prescribing in the country that urgently needs to be addressed. 
 
Conclusion 
The findings in this pilot survey demonstrated a high frequency of antibiotic prescribing 
among the doctors in this leading tertiary hospital in Nigeria and the indications of 
inappropriate antibiotic prescribing. There is an urgent need to follow up these findings 
with a more extensive survey with national coverage to define the problem in greater 
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detail and institute evidence based institutional policies and guidelines for promoting 
rational antimicrobial use across Nigeria. Efforts towards establishment of ASPs and 
DTCs have commenced in this hospital following analysis of the findings to address 
highlighted concerns, and will be followed up in future studies. 
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